Stocktoria

CalciMedica, Inc. CALC

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-09-25

CalciMedica, Inc. statistics & valuation

Market cap$12.9M
Return on capital-235.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2019202020212022202320242025
Operating margin (%)
2019202020212022202320242025
Return on equity (%)
-29.00% -421.20% -95.10% 2019202020212022202320242025
Shares outstanding
1.4M 21.0M 21.4M 84165 5.8M 13.5M 15.4M 2019202020212022202320242025
Net debt ($)
2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-91.10% -27.00% -51.80% -233.60% -282.00% -69.20% -217.50% 2019202020212022202320242025
Free cash flow margin (%)
2019202020212022202320242025
Debt / equity (×)
2019202020212022202320242025
EPS ($)
-$1.69 -$111.16 -$7.66 -$1.22 -$1.97 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Return on assets-217.5%-69.2%-282.0%-233.6%-51.8%-27.0%-91.1%
Return on equity445.1%-95.1%-421.2%11.0%56.0%-29.0%36.0%
Current ratio3.585.342.880.3616.5314.182.96

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.